La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « AffRegion.i » - entrée « Occitanie (région administrative) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nouvelle-Aquitaine < Occitanie (région administrative) < Ohio  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 266.
[0-20] [0 - 20][0 - 50][20-40]**** probable Xml problem ****
Ident.Authors (with country if any)Title
000021 (1999) O. Rascol [France]Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?
000028 (1999) O. Rascol [France] ; O. Blin ; C. Thalamas ; S. Descombes ; C. Soubrouillard ; P. Azulay ; N. Fabre ; F. Viallet ; K. Lafnitzegger ; S. Wright ; J H Carter ; J G NuttABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease.
000036 (1999) O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L MontastrucClinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
000040 (1999) M B Delisle [France] ; J R Murrell ; R. Richardson ; J A Trofatter ; O. Rascol ; X. Soulages ; M. Mohr ; P. Calvas ; B. GhettiA mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy.
000042 (1999) C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. RascolLack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
000062 (1999) O. Rascol [France]L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
000070 (1999) F. Torreilles [France] ; S. Salman-Tabcheh ; M. Guérin ; J. TorreillesNeurodegenerative disorders: the role of peroxynitrite.
000074 (1999) S. Champagne [France] ; E. Coste ; H. Peyrière ; J. Nigond ; E. Mania ; M. Pons ; D. Hillaire-Buys ; P. Balmes ; J P Blayac ; J M DavyChronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
000116 (2000) O. Rascol [France] ; D J Brooks ; A D Korczyn ; P P De Deyn ; C E Clarke ; A E LangA five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.
000127 (2000) O. Rascol [France] ; J L Montastruc[Role of dopaminergic agonists].
000132 (2000) J J Ferreira [France] ; O. RascolPrevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.
000137 (2000) O. Rascol [France]The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease.
000163 (2001) O. Rascol [France] ; J G Nutt ; O. Blin ; C G Goetz ; J M Trugman ; C. Soubrouillard ; J H Carter ; L J Currie ; N. Fabre ; C. Thalamas ; W W Giardina ; S. WrightInduction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
000165